July 2021

The immunological imprinting condition the response to SARS-CoV-2

A study by IDIBELL, Bellvitge Hospital, and the Icahn School of Medicine at Mount Sinai has shown for the first time that pre-existing immunity against other coronaviruses influences a possible immunity against SARS-CoV-2

The immunological imprinting condition the response to SARS-CoV-2 Read More »

Described two new variants of the TLR7 gene associated with severe COVID-19 in young and healthy men

The sequencing of the TLR7 gene in 14 young men with no medical history reveals the presence of two genetic variants that affect the immune response.

Described two new variants of the TLR7 gene associated with severe COVID-19 in young and healthy men Read More »

New advances in the understanding of the pathophysiology of megalencephalic leukoencephalopathy (MLC) minority brain disease

Two recent articles with the participation of a research group from IDIBELL, the University of Barcelona, and CIBERER describe different protein interactions of MLC1 and GlialCAM that could regulate neuronal development and activity.

New advances in the understanding of the pathophysiology of megalencephalic leukoencephalopathy (MLC) minority brain disease Read More »

IDIBELL and ICO participate in the discovery of a weakness that could be used to treat defective cancers for SMARCA4

The study suggests that tumors with a genetically inactivated form of the chromatin remodeling protein SMARCA4 are highly sensitive to inhibitors of the KDM6 family of histone demethylases.

IDIBELL and ICO participate in the discovery of a weakness that could be used to treat defective cancers for SMARCA4 Read More »

Discovered a new strategy to fight the metastatic melanoma

It has shown that the combination of chemotherapy with a BRAF oncogene inhibitor effectively treats this disease. This alternative opens the door to offer a new approach to patients affected by this type of tumor, which does not have a curative treatment in the more advanced stages or those with relapse.

Discovered a new strategy to fight the metastatic melanoma Read More »

The impact of obesity is becoming increasingly important in kidney transplantation

A study by the Nephrology and Renal Transplantation research group of IDIBELL and the Bellvitge University Hospital (HUB) highlights the need to raise awareness among both transplant candidates and potential donors

The impact of obesity is becoming increasingly important in kidney transplantation Read More »

A new study defines an epigenetic predisposition to suffer leukemia or lymphoma induced by the infection of the HTLV-1 virus

A study, with the participation of IDIBELL and ICO, published in Molecular Cancer, has described that people with epigenetic alterations in the FHIT tumor suppressor gene are more predisposed to developing the disease.

A new study defines an epigenetic predisposition to suffer leukemia or lymphoma induced by the infection of the HTLV-1 virus Read More »

Scroll to Top